Zoe's Business Solutions

 Hi all, Budgeting is an integral part of human and business life. You cannot move an inch ahead unless you have planned the finances in a logical manner. You need to identify the available funds, the expected expenses and the estimated income for a defined time period with the help of a bookkeeper to maintain the cash flow of the business. Without this knowledge, you cannot survive the challenges and the upheavals that can affect the business financially and lead to deficits and bad debts. Budgeting ensures that you can meet your objectives and have the capital needed to complete all the projects and tasks. To know more about budgeting, read the article shared below.   https://www.agibookkeeping.com.au/why-budgeting-is-important-for-businesses/

 Mining magnate Andrew ‘Twiggy’ Forrest has backed new biotech venture capital group Tenmile to the tune of $250 million in a move that he hopes will fast-track the development of ‘life-changing’ health technology. Tattarang, the private investment company founded by Forrest and his wife Nicola, has declared the placement as an initial investment in Tenmile which is being led by Steve Burnell, a former executive of biotech giant Roche Group with an extensive career in the technology and healthcare sectors including experience in mergers and acquisitions. Tenmile has a number of key investments in its portfolio including the listed Emyria (ASX: EMD), which produces synthetic CBD-based products. The Forrests made a separate $5 million investment in Emyira in November last year through Tatterang, taking a 7.3 per cent interest in the company. Read More: https://www.businessnewsaustralia.com/articles/forrest-aims-to-fast-track-life-changing-health-tech-with--250m-investment-in-tenmile.html

 Australia’s dominant online vehicle marketplace Carsales.com (ASX: CAR) is firing on all cylinders with buoyant conditions in its domestic and international operations leading to a 23 per cent increase in FY22 profit to $160.8 million. The result has been bolstered by a bigger contribution from US vehicle marketplace Trader Interactive after Carsales.com earlier this year bought out the remaining 51 per cent it didn’t already own for about $1.17 billion. Trader Interactive is expected to deliver low double-digit earnings per share growth in the first full year of ownership, with higher upside in the following years. Carsales.com posted a 19 per cent increase in revenue to $509.1 million in FY22, while underlying EBITA rose 12 per cent to $269.9 million. Read More: https://www.businessnewsaustralia.com/articles/carsales-com-firing-on-all-cylinders-as-profit-accelerates-23-per-cent-to--161m.html

 Synthetic cannabinoid-based product developer Emyria (ASX: EMD) has been given the green light to proceed with a Phase 3 clinical trial of its first ultra-pure CBD candidate, EMD-RX5, in a major milestone for the company. The trial, supported by Emyria’s clinical service subsidiary Emerald Clinics, is aimed at assessing the efficacy of two dose strengths of EMD-RX5 to treat the psychological distress of patients suffering from chronic pain. A successful trial will support Emyria’s registration of EMD-RX5 with the Therapeutic Goods Administration as a Schedule 3, over-the-counter treatment. Read More: https://www.businessnewsaustralia.com/articles/emyria-gets-green-light-for-final-trials-of-cbd-pain-distress-treatment.html